Sanford-Burnham Medical Research Institute and Pfizer have entered into a three-year collaboration to identify new therapeutic targets for preventing and treating complications of obesity and diabetes using novel screening tools, including systems-biology approaches and technologies developed at Sanford-Burnham.   Sanford-Burnham and Pfizer will collaborate to identify and validate new targets for drug discovery. Investigators will use Sanford-Burnham’s Conrad Prebys Center for Chemical Ge...